Analysis of <em>RHOA</em> mutations and their significance in the proliferation and transcriptome of digestive tract cancer cells

Ikari,Naoki; Serizawa,Akiko; Tanji,Etsuko; Yamamoto,Masakazu; Furukawa,Toru

doi:10.3892/ol.2021.12996

Analysis of RHOA mutations and their significance in the proliferation and transcriptome of digestive tract cancer cells

Authors:
- Naoki Ikari
- Akiko Serizawa
- Etsuko Tanji
- Masakazu Yamamoto
- Toru Furukawa
View Affiliations

Affiliations: Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162‑8666, Japan, Institute for Integrated Medical Sciences, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162‑8666, Japan
Published online on: August 11, 2021 https://doi.org/10.3892/ol.2021.12996
Article Number: 735
Copyright: © Ikari et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The ras homolog family member A (RHOA) gene encodes a member of the Rho family of small GTPases and is known to function in reorganization of the actin cytoskeleton, which is associated with regulation of cell shape, attachment and motility. RHOA has been found to be recurrently mutated in gastrointestinal cancer; however, the functional significance of the mutated RHOA protein in digestive tract cancers remains to be uncovered. The aim of the present study was to understand the role of mutant RHOA in the proliferation and transcriptome of digestive tract cancer cells. Mutations of RHOA in one esophageal cancer cell line, OE19, eight gastric cancer cell lines, namely, AGS, GCIY, HGC‑27, KATO III, MKN1, MKN45, SNU16 and SNU719, as well as two colon cancer cell lines, CCK‑81 and SW948, were determined using Sanger sequencing. The results uncovered several mutations, including p.Arg5Gln and p.Tyr42Cys in CCK‑81, p.Arg5Trp and p.Phe39Leu in SNU16, p.Gly17Glu in SW948, p.Tyr42Ser in OE19, p.Ala61Val in SNU719, p.Glu64del in AGS. Wild‑type RHOA was identified in GCIY, HGC‑27, KATO III, MKN1 and MKN45. Knockdown of RHOA using small interfering RNA attenuated the in vitro proliferation in the three‑dimensional culture systems of GCIY, MKN1, OE19 and SW948, whereas no apparent changes were seen in CCK‑81, HGC‑27 and SNU719. Transcriptome analysis revealed that downregulation of the long non‑coding RNA (lnc)‑DERA‑1 was observed in all tested cell lines following RHOA knockdown in the RHOA‑mutated cell lines. Gene Ontology analysis showed that the genes associated with small molecule metabolic process, oxidation‑reduction processes, protein kinase activity, transport, and cell junction were commonly downregulated in cells whose proliferation was attenuated by the knockdown of RHOA. These results suggested that certain RHOA mutations may result in upregulation of lnc‑DERA‑1 and genes associated with cellular metabolism and proliferation in digestive tract cancers.

View Figures

View References

1	Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, et al: Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet. 46:583–587. 2014. View Article : Google Scholar : PubMed/NCBI
2	Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, et al: Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 46:573–582. 2014. View Article : Google Scholar : PubMed/NCBI
3	Ushiku T, Ishikawa S, Kakiuchi M, Tanaka A, Katoh H, Aburatani H, Lauwers GY and Fukayama M: RHOA mutation in diffuse-type gastric cancer: A comparative clinicopathology analysis of 87 cases. Gastric Cancer. 19:403–411. 2016. View Article : Google Scholar : PubMed/NCBI
4	Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Diehl JN, Papageorge AG, Stachler MD, Liao J, Zhou J, et al: Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer. Cancer Discov. 10:288–305. 2020. View Article : Google Scholar : PubMed/NCBI
5	Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, Muto H, Tsuyama N, Sato-Otsubo A, Okuno Y, et al: Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 46:171–175. 2014. View Article : Google Scholar : PubMed/NCBI
6	Chang HR, Nam S, Lee J, Kim JH, Jung HR, Park HS, Park S, Ahn YZ, Huh I, Balch C, et al: Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer. Oncotarget. 7:81435–81451. 2016. View Article : Google Scholar : PubMed/NCBI
7	Korourian A, Roudi R, Shariftabrizi A and Madjd Z: MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells. Exp Biol Med (Maywood). 242:1842–1847. 2017. View Article : Google Scholar : PubMed/NCBI
8	Zhao X, Lu L, Pokhriyal N, Ma H, Duan L, Lin S, Jafari N, Band H and Band V: Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Res. 69:483–491. 2009. View Article : Google Scholar : PubMed/NCBI
9	Ideo H, Seko A and Yamashita K: Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem. 280:4730–4737. 2005. View Article : Google Scholar : PubMed/NCBI
10	Ma C, Xie J, Luo C, Yin H, Li R, Wang X, Xiong W, Zhang T, Jiang P, Qi W, et al: OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF-C expression and secretion. Int J Oncol. 54:572–584. 2019.PubMed/NCBI
11	Ohashi N, Kodera Y, Nakanishi H, Yokoyama H, Fujiwara M, Koike M, Hibi K, Nakao A and Tatematsu M: Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Int J Oncol. 27:637–644. 2005.PubMed/NCBI
12	Kim YI, Lee HJ, Khang I, Cho BN and Lee HK: Selective inhibition of cell growth by activin in SNU-16 cells. World J Gastroenterol. 12:3000–3005. 2006. View Article : Google Scholar : PubMed/NCBI
13	Kuboki Y, Shimizu K, Hatori T, Yamamoto M, Shibata N, Shiratori K and Furukawa T: Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 44:227–235. 2015. View Article : Google Scholar : PubMed/NCBI
14	Fennema E, Rivron N, Rouwkema J, van Blitterswijk C and de Boer J: Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol. 31:108–115. 2013. View Article : Google Scholar : PubMed/NCBI
15	Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D and Thomas PD: PANTHER version 11: Expanded annotation data from gene ontology and reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 45:D183–D189. 2017. View Article : Google Scholar : PubMed/NCBI
16	Liu J, McCleland M, Stawiski EW, Gnad F, Mayba O, Haverty PM, Durinck S, Chen YJ, Klijn C, Jhunjhunwala S, et al: Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer. Nat Commun. 5:38302014. View Article : Google Scholar : PubMed/NCBI
17	Mouradov D, Sloggett C, Jorissen RN, Love CG, Li S, Burgess AW, Arango D, Strausberg RL, Buchanan D, Wormald S, et al: Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res. 74:3238–3247. 2014. View Article : Google Scholar : PubMed/NCBI
18	Liu N, Bi F, Pan Y, Sun L, Xue Y, Shi Y, Yao X, Zheng Y and Fan D: Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res. 10:6239–6247. 2004. View Article : Google Scholar : PubMed/NCBI
19	Kuo PL, Huang YL, Hsieh CC, Lee JC, Lin BW and Hung LY: STK31 is a cell-cycle regulated protein that contributes to the tumorigenicity of epithelial cancer cells. PLoS One. 9:e933032014. View Article : Google Scholar : PubMed/NCBI
20	Hsu WC, Le HN, Lin YJ, Chen MC, Wang TF, Li CC, Kuo WW, Mahalakshmi B, Singh CH, Chen MC and Huang CY: Calmodulin/CaMKII-γ mediates prosurvival capability in apicidin-persistent hepatocellular carcinoma cells via ERK1/2/CREB/c-fos signaling pathway. J Cell Biochem. 122:612–625. 2021. View Article : Google Scholar : PubMed/NCBI
21	Xie Q, Lin T, Zhang Y, Zheng J and Bonanno JA: Molecular cloning and characterization of a human AIF-like gene with ability to induce apoptosis. J Biol Chem. 280:19673–19681. 2005. View Article : Google Scholar : PubMed/NCBI
22	Kofler M, Speight P, Little D, Di Ciano-Oliveira C, Szászi K and Kapus A: Mediated nuclear import and export of TAZ and the underlying molecular requirements. Nat Commun. 9:49662018. View Article : Google Scholar : PubMed/NCBI